| 产品描述: | F 16915, a Docosahexaenoic Acid (DHA) derivative, is a potent pro-agent of DHA. F 16915 can prevent heart failure-induced atrial fibrillation. |
| 体内研究: |
F 16915 (100 mg/kg; daily oral gavage for 2 months) reduces marked dilation of the left atrial (LA) cavity and the steep decline of left ventricular (LV) contractile function occurring 2 months after infarction and reperfusion in rats. F 16915 (1-5 g/d 웿 Ů ñ 샮㡽䇘睜⪰ޏࠃ 䇩睜 |
| 参考文献: |
1. Le Grand B, et al. F 16915 prevents heart failure-induced atrial fibrillation: a promising new drug as upstream therapy. Naunyn Schmiedebergs Arch Pharmacol. 2014 Jul;387(7):667-77.
|
| 保存条件: |
-20°C, 避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.383 ml |
11.916 ml |
23.832 ml |
| 5 mM |
0.477 ml |
2.383 ml |
4.766 ml |
| 10 mM |
0.238 ml |
1.192 ml |
2.383 ml |
| 50 mM |
0.048 ml |
0.238 ml |
0.477 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |